James Shin Profile - Deutsche Bank Analyst
4 Followers
James Shin's Stock Coverage
| LLYEli Lilly & Co | May 07, 2026 | BUY | Reiterated | $1,285.00 | 20Ratings | +24.27% | ||
| AAPGAscentage Pharma Group International Unsponsored ADR | Apr 24, 2026 | BUY | Initiated | $40.00 | 1Ratings | -36.80% | ||
| STROSutro Biopharma | Mar 25, 2026 | BUY | Reiterated | $55.00 | 4Ratings | -15.75% | ||
| LEGNLegend Biotech | Mar 09, 2026 | BUY | Reiterated | $60.00 | 3Ratings | -9.60% | ||
| MRKMerck & Company | Feb 13, 2026 | BUY | Upgraded | $150.00 | 9Ratings | -12.05% | ||
| ABBVAbbVie | Sep 15, 2025 | HOLD | Reiterated | $204.00 | 7Ratings | ― | ― | |
| GILDGilead Sciences | Aug 11, 2025 | BUY | Reiterated | $135.00 | 5Ratings | +32.35% | ||
| IMTXImmatics | May 28, 2025 | BUY | Initiated | $10.00 | 1Ratings | +122.70% | ||
| IMCRImmunocore Holdings | May 27, 2025 | BUY | Initiated | $65.00 | 1Ratings | -10.90% | ||
| BMYBristol-Myers Squibb | Feb 10, 2025 | HOLD | Reiterated | $53.00 | 7Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >James Shin activity FAQ
What is the performance of James Shin's recommendations?
The percentage of profitable recommendations made by James Shin is 54.05%, and the average return per transaction is 2.20%.
What stocks does James Shin cover?
James Shin mostly covers Eli Lilly & Co, Ascentage Pharma Group International Unsponsored ADR, Sutro Biopharma stocks.
What was James Shin's most profitable rating?
James Shin’s most profitable rating was a buy on Immatics stock on May 28, 2025. The return on the trade was 122.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here